secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2023-09-05T23:59:59+00:00
Accession:  0001558370-23-015462
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health names Joshua DeTillio COO; base salary $425K, bonus up to 70%
--------------------------------------------------------------------------

- Joshua DeTillio appointed COO effective October 2, 2023; 20+ years healthcare leadership experience.
- Base annual salary of $425,000; eligible for annual cash bonus up to 70% of base salary.
- Severance of 12 months base salary plus medical subsidy if terminated without cause or resignation for good reason.
- Eligible for long-term incentive plan; RSU awards capped at 70% of base salary; $50,000 relocation reimbursement.
- Previously served as CEO of Bravera Health (Community Health Systems) and Palms West Hospital (HCA).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000155837023015462/0001558370-23-015462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000155837023015462/nutx-20230828x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-015462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer